Treatment with antiviral drug remdesivir may not significantly speed up recovery from COVID-19 in critically ill hospitalised patients compared to placebo, according to the first randomised trial of its kind published in The Lancet journal. The study led by researchers from China-Japan Friendship Hospital and Capital Medical University in China involved 237 adults aged 18 and older from ten hospitals in Wuhan.
from IndiaTV World: Google News Feed https://ift.tt/2yVKAIp
from IndiaTV World: Google News Feed https://ift.tt/2yVKAIp
Comments
Post a Comment